Abstract:The JCOG1008 trial revealed non-inferiority of chemoradiotherapy with weekly cisplatin to that with tri-weekly cisplatin in terms of the overall survival in patients with postoperative high-risk locally advanced squamous cell carcinoma of the head and neck. We developed clinical pathways to standardize and optimize the weekly cisplatin treatment procedure, minimize adverse events, and promote the patients' understanding. The regimen ensures a sufficient amount of hydration during the short-term overnight hospi… Show more
Set email alert for when this publication receives citations?
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.